drugset / Trial / NCT04322032
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389
RandomizedCrossoverOpen-labelTreatment
Summary
This study is a randomized, open-label, fasted, single dose, crossover study to evaluate the pharmacokinetic profiles and safety of CKD-389 in healthy volunteers.
Timeline
- Start
- 2020-04-06
- Primary completion
- 2020-05-12
- Completion
- 2020-05-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-389 | Unknown | — | Oral |
| Subject | D308 | Unknown | — | Oral |
| Subject | D759 | Unknown | — | Oral |